A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Elens, L. [1 ]
Bouarmar, R. [2 ]
Hesselink, D. A. [3 ]
Haufroid, V. [4 ]
van Gelder, T.
van Schaik, R. H. [1 ,3 ]
机构：
[1] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[3] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[4] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [1] A new CYP3A4 polymorphism is associated with an increased risk of renal toxicity in cyclosporin-treated kidney transplant recipients
    Elens, L.
    Bouamar, R.
    Hesselink, D.
    Haufroid, V
    van Gelder, T.
    van Schaik, R.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 480 - 480
  • [2] The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients
    Elens, Laure
    Bouamar, Rachida
    Hesselink, Dennis A.
    Haufroid, Vincent
    van Gelder, Teun
    van Schaik, Ron H. N.
    PHARMACOGENETICS AND GENOMICS, 2012, 22 (05): : 373 - 380
  • [3] The CYP3A4*22 Allelic Variant Increases the Risk of Tacrolimus Overexposure in Kidney Transplant Recipients.
    Nicolas, P.
    Manele, E.
    Isebelle, E.
    Mathias, B.
    Gabriel, C.
    Guy, T.
    Cecile, V.
    Bruno, M.
    Yann, L.
    Eric, T.
    TRANSPLANTATION, 2014, 98 : 676 - 676
  • [4] The CYP3A4*22 Allelic Variant Increases the Risk of Tacrolimus Overexposure in Kidney Transplant Recipients.
    Nicolas, P.
    Manele, E.
    Isebelle, E.
    Mathias, B.
    Gabriel, C.
    Guy, T.
    Cecile, V.
    Bruno, M.
    Yann, L.
    Eric, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 676 - 676
  • [5] A new functional CYP3A4 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients
    Elens, L.
    Bouamar, R.
    Hesselink, D.
    Haufroid, V
    van der Heiden, I
    van Gelder, T.
    van Schaik, R.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 507
  • [6] The CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes
    Okubo, Maho
    Murayama, Norie
    Shimizu, Makiko
    Shimada, Tsutomu
    Guengerich, F. Peter
    Yamazaki, Hiroshi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2013, 38 (03): : 349 - 354
  • [7] Pharmacogenomic effects of a polymorphism in the 5′ promotor region of CYP3A4 in stable kidney transplant recipients.
    Karlix, JL
    Walker, JR
    Myers, HA
    Johary, CF
    Faramie, WJ
    Reed, AI
    Silkensen, JR
    Van der Werf, WJ
    Hemming, AW
    Crabtree, JM
    Srinivas, TR
    Patton, PR
    Howard, RJ
    TRANSPLANTATION, 2000, 69 (08) : S220 - S220
  • [8] THE NEW CYP3A4 INTRON 6 POLYMORPHISM (CYP3A4*22) IS SIGNIFICANTLY ASSOCIATED WITH DECREASED TACROLIMUS METABOLISM.
    van Schaik, R. H.
    Elens, L.
    Bouamar, R.
    Hesselink, D. A.
    Haufroid, V.
    van Gelder, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S107 - S107
  • [9] Effect of the New Functional CYP3A4*22, CYP3A5 and ABCB1 Polymorphisms On the Tacrolimus Concentrations in Hispanic Kidney Transplant Recipients.
    Vu, D.
    Qwak, H.
    Sakharkar, P.
    Kim, J.
    Shah, T.
    Hutchinson, I.
    Naraghi, R.
    Min, D.
    TRANSPLANTATION, 2014, 98 : 888 - 889
  • [10] Effect of the New Functional CYP3A4*22, CYP3A5 and ABCB1 Polymorphisms On the Tacrolimus Concentrations in Hispanic Kidney Transplant Recipients.
    Vu, D.
    Qwak, H.
    Sakharkar, P.
    Kim, J.
    Shah, T.
    Hutchinson, I.
    Naraghi, R.
    Min, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 888 - 889
12345